Profil
Darrell J.
Elliott currently works at Isuma Strategies, Inc., as President & Co-Chief Executive Officer from 2007, ADERIS Pharmaceuticals, Inc., as Director, IsoTis SA, as Director, Prospiva Capital (VCC), Inc., as Director, Discovery Parks Holdings Ltd., as Director from 2007, and Invivos Partners Ltd., as Director from 2006.
Mr. Elliott also formerly worked at ViRexx Medical Corp., as Chairman & Interim Chief Executive Officer from 2007 to 2008, Calyx Ventures, Inc., as Chairman, President, CEO & CFO, 1322256 Alberta Ltd., as Chairman, Chromos Molecular Systems, Inc., as Chairman, Aztech Innovations, Inc., as Chairman, Nventa Biopharmaceuticals Corp., as Director, SMC Ventures, Inc., as Director, Neuromed Pharmaceuticals, Inc., as Director, IsoTis, Inc., as Director, Arbutus Biopharma Corp., as Director, Auricle Biomedical Corp., as Director from 2007 to 2010, Transformative Ventures Ltd., as Director, Trenchant Capital Corp., as Director, Lumira Capital Investment Management, Inc., as Managing Director from 1999 to 2006, Cognetix, Inc., as Director, Agrisoma Biosciences, Inc., as Director, Neuromed Pharmaceuticals Ltd., as Director, North American Healthcare International, Inc., as Managing Director, Jana Care, Inc., as Director, Canadian Medical Discoveries Fund, Inc., as Vice President, RBC Capital Partners Ltd., as Regional Vice President from 1990 to 1999, and MDS Ventures Pacific, Inc., as President from 1999 to 2006.
Mr. Elliott received his undergraduate degree in 1974 from the University of South Africa.
Postes actifs de Darrell J. Elliott
| Sociétés | Poste | Début |
|---|---|---|
ADERIS Pharmaceuticals, Inc.
ADERIS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs and pharmaceuticals | Directeur/Membre du Conseil | - |
Isuma Strategies, Inc. | Directeur Général | 01/10/2007 |
IsoTis SA
IsoTis SA BiotechnologyHealth Technology Develops biomedical products | Directeur/Membre du Conseil | - |
Prospiva Capital (VCC), Inc. | Directeur/Membre du Conseil | 23/11/2009 |
Discovery Parks Holdings Ltd. | Directeur/Membre du Conseil | 06/09/2010 |
Invivos Partners Ltd. | Directeur/Membre du Conseil | 06/09/2010 |
Anciens postes connus de Darrell J. Elliott
| Sociétés | Poste | Fin |
|---|---|---|
Aztech Innovations, Inc.
Aztech Innovations, Inc. Electrical ProductsProducer Manufacturing Engages in clean technology and energy conservation | Président | 27/04/2011 |
Transformative Ventures Ltd.
Transformative Ventures Ltd. Financial ConglomeratesFinance A capital pool company | Directeur/Membre du Conseil | 22/04/2010 |
Auricle Biomedical Corp.
Auricle Biomedical Corp. Financial ConglomeratesFinance Capital pool company | Directeur/Membre du Conseil | 22/04/2010 |
| ░░░░░░ ░░░░░░░░░░░░░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░ ░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Darrell J. Elliott
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 29 |
|---|---|
Nventa Biopharmaceuticals Corp.
Nventa Biopharmaceuticals Corp. Medical SpecialtiesHealth Technology Discovers, develops and commercializes innovative stress protein-based therapeutic vaccines | Health Technology |
ADERIS Pharmaceuticals, Inc.
ADERIS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs and pharmaceuticals | Health Technology |
SMC Ventures, Inc.
SMC Ventures, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a development stage company | Commercial Services |
1322256 Alberta Ltd.
1322256 Alberta Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Chromos Molecular Systems, Inc.
Chromos Molecular Systems, Inc. BiotechnologyHealth Technology Manufactures biological products | Health Technology |
ViRexx Medical Corp.
ViRexx Medical Corp. Pharmaceuticals: MajorHealth Technology Develops, researches, and commercializes biopharmaceutical products for the treatment of hepatitis B, C, and solid tumors | Health Technology |
Neuromed Pharmaceuticals, Inc.
Neuromed Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops chronic pain drugs | Health Technology |
IsoTis, Inc.
IsoTis, Inc. Medical SpecialtiesHealth Technology Designs, develops, manufactures, and sells bone graft substitutes and other devices | Health Technology |
Arbutus Biopharma Corp.
Arbutus Biopharma Corp. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics which targets viral diseases | Health Technology |
Auricle Biomedical Corp.
Auricle Biomedical Corp. Financial ConglomeratesFinance Capital pool company | Finance |
Transformative Ventures Ltd.
Transformative Ventures Ltd. Financial ConglomeratesFinance A capital pool company | Finance |
Aztech Innovations, Inc.
Aztech Innovations, Inc. Electrical ProductsProducer Manufacturing Engages in clean technology and energy conservation | Producer Manufacturing |
Trenchant Technologies Capital Corp.
Trenchant Technologies Capital Corp. Other Metals/MineralsNon-Energy Minerals Operates as a private equity firm | Non-Energy Minerals |
Canadian Medical Discoveries Fund, Inc.
Canadian Medical Discoveries Fund, Inc. Investment ManagersFinance Venture Capital Fund | Finance |
Lumira Capital Investment Management, Inc.
Lumira Capital Investment Management, Inc. Investment ManagersFinance LUMIRA invests in revenue stage companies that are both privately held and publically traded companies located in the Canada and the United States. The firm focuses on sectors of therapeutic products and medical devices. It participates in the early stage capital financing. | Finance |
IsoTis SA
IsoTis SA BiotechnologyHealth Technology Develops biomedical products | Health Technology |
RBC Capital Partners Ltd.
RBC Capital Partners Ltd. Investment ManagersFinance RBC Capital Partners invests in companies located in US and Canada with historical stable cash flows, experienced management and competitive advantages. The fund targets companies operating in the fields of growth manufacturing, business services, consumer products, restaurants, retail, and oil & gas, IT and healthcare services. It provides financing for acquisitions, financial sponsor buyouts, shareholder buyouts, management buyouts, senior debt relief, growth capital requirements with an investment size in the range of $3 - $20 million, an EBITDA up to $3 million and an Enterprise Value greater than $10 million. | Finance |
Cognetix, Inc.
Cognetix, Inc. Drugstore ChainsRetail Trade Discovers and develops drugs | Retail Trade |
Agrisoma Biosciences, Inc.
Agrisoma Biosciences, Inc. Chemicals: SpecialtyProcess Industries Provides crop technology for biofuel and renewable energy solutions | Process Industries |
Neuromed Pharmaceuticals Ltd.
Neuromed Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops chronic pain drugs | Health Technology |
MDS Ventures Pacific, Inc.
MDS Ventures Pacific, Inc. Financial ConglomeratesFinance Operates as an investment firm | Finance |
University of South Africa
University of South Africa Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Isuma Strategies, Inc. | |
Calyx Ventures, Inc.
Calyx Ventures, Inc. Information Technology ServicesTechnology Services Develops custom software for enterprises and start-up companies | Technology Services |
North American Healthcare International, Inc.
North American Healthcare International, Inc. Real Estate DevelopmentFinance Provides land development and hospital services | Finance |
Prospiva Capital (VCC), Inc. | |
Discovery Parks Holdings Ltd. | |
Invivos Partners Ltd. | |
Jana Care, Inc.
Jana Care, Inc. Medical SpecialtiesHealth Technology Develops point-of-care diagnostic tools and digital platforms for chronic disease management | Health Technology |
















